Edition:
United Kingdom

X T L Biopharmaceuticals Ltd (XTLB.OQ)

XTLB.OQ on NASDAQ Stock Exchange Capital Market

1.99USD
18 Jan 2019
Change (% chg)

$0.13 (+6.99%)
Prev Close
$1.86
Open
$2.07
Day's High
$2.07
Day's Low
$1.99
Volume
535
Avg. Vol
5,310
52-wk High
$3.91
52-wk Low
$1.43

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 0.002
Jun '18 0.00 0.000
Mar '18 0.00 0.002
FY 2017 Dec '17 0.00 0.000
Sep '17 0.003
Jun '17 -0.003
Mar '17 -0.003
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.71 33.71
P/E High - Last 5 Yrs. 329.55 148.01 49.93
P/E Low - Last 5 Yrs. 329.55 47.79 24.27
Beta -0.08 1.08 0.90
Price to Sales (TTM) -- 49.51 6.28
Price to Book (MRQ) 0.67 10.16 5.27
Price to Tangible Book (MRQ) 6.40 13.82 6.79
Price to Cash Flow (TTM) -- 52.80 24.84
% Owned Institutions 1.12 3.75 1.69

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.40
Dividend Yield - 5 Year Avg -- 0.09 1.42
Dividend 5 Year Growth Rate -- 0.79 4.83
Payout Ratio(TTM) -- 7.04 41.08

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 130.03 9.72
Sales (TTM) vs TTM 1 Yr. Ago -- 47.85 5.87
Sales - 5 Yr. Growth Rate -- 22.76 11.20
EPS (MRQ) vs Qtr. 1 Yr. Ago -34.50 75.87 47.26
EPS (TTM) vs TTM 1 Yr. Ago 21.36 -- --
EPS - 5 Yr. Growth Rate -- 12.03 10.82
Capital Spending - 5 Yr. Growth Rate 40.63 9.24 15.18

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.26
Current Ratio (MRQ) 17.78 3.43 3.08
LT Debt to Equity (MRQ) -- 18.73 11.38
Total Debt to Equity (MRQ) -- 31.43 16.13
Interest Coverage (TTM) -- -43.27 29.51

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.29 53.78
Gross Margin - 5 Yr. Avg. -- 60.55 52.17
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -110.23 12.87
Operating Margin (TTM) -- -184.42 6.20
Operating Margin - 5 Yr. Avg. -- -126.67 8.31
Pre-Tax Margin (TTM) -- -175.20 7.17
Pre-Tax Margin - 5 Yr. Avg. -- -132.83 8.61
Net Profit Margin (TTM) -- -181.93 3.30
Net Profit Margin - 5 Yr. Avg. -- -137.23 4.88
Effective Tax Rate (TTM) -- 21.48 22.88
Effective Tax Rate - 5 Yr. Avg. -- 15.57 23.39

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 7,650,695 844,239,566
Net Income/Employee (TTM) -- 652,572 100,064,145
Receivable Turnover (TTM) -- 6.25 5.72
Inventory Turnover (TTM) -- 1.89 3.48
Asset Turnover (TTM) 0.00 0.32 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -67.01 6.45 11.08
Return on Assets - 5 Yr. Avg. -30.54 5.52 12.21
Return on Investment (TTM) -70.95 8.99 14.48
Return on Investment - 5 Yr. Avg. -39.11 6.85 15.88
Return on Equity (TTM) -125.01 10.13 15.99
Return on Equity - 5 Yr. Avg. -32.85 8.39 17.00
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 32.39 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for X T L Biopharmaceuticals Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 4.49%
# of Holders: 5
Total Shares Held: 231,071
3 Mo. Net Change: 0
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 0
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.